The right combination: Overcoming drug resistance in cancer
Overactive epidermal growth factor receptor (EGFR) signaling has been linked to the development of cancer. Several drug therapies have been developed to treat these EGFR-associated cancers; however, many patients have developed ...
Cancer
Jun 01, 2012 |
not rated yet |
0
Researchers discover drug target for stimulating recovery from stroke
Investigators at the Stanford University School of Medicine have shown that removing a matched set of molecules that typically help to regulate the brain's capacity for forming and eliminating connections between nerve cells ...
Neuroscience
Mar 21, 2012 |
5 / 5 (2) |
0
|
Experimental drug reduces cortisol levels, improves symptoms in Cushing's disease
A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of this endocrine disorder ever conducted. Results of the clinical trial conducted ...
Medical research
Mar 07, 2012 |
5 / 5 (1) |
0
|
First study on long-term cognitive effects of breast cancer CMF chemotherapy finds subtle impairment
Dutch investigators have reported that women who received CMF chemotherapy (a combination regimen including the drugs cyclophosphamide, methotrexate, and 5-fluorouracil) for breast cancer between 1976 and 1995 scored worse ...
Cancer
Feb 27, 2012 |
4.7 / 5 (3) |
0
|
New melanoma drug Zelboraf nearly doubles survival in majority of patients
Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.
Cancer
Feb 22, 2012 |
5 / 5 (2) |
0
|
Heart hormone helps shape fat metabolism
It's well known that exercising reduces body weight because it draws on fat stores that muscle can burn as fuel. But a new study at Sanford-Burnham Medical Research Institute (Sanford-Burnham) suggests that ...
Medical research
Feb 06, 2012 |
5 / 5 (3) |
0
|
Ganetespib showed activity in KRAS-mutant NSCLC as monotherapy and in combinations
The investigational drug ganetespib, a synthetic second-generation Hsp90 inhibitor, slowed the growth of cancer cells taken from non-small cell lung cancer tumors with a mutation in the KRAS gene. The drug was even more active ...
Cancer
Jan 11, 2012 |
not rated yet |
0
US warned French implant maker as far back as 2000
The US Food and Drug Administration warned a French maker of breast implants now feared to be at risk of rupture of "serious" quality control violations involving saline implants back in 2000.
Other
Dec 28, 2011 |
5 / 5 (1) |
1
RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer
Over 17,000 patients will have been diagnosed with locally-advanced pancreatic cancer in the United States in 2011. Surgery is not a treatment option for these patients whose tumor has grown beyond the pancreas to surrounding ...
Cancer
Dec 14, 2011 |
5 / 5 (2) |
0
Researchers discover Achilles' heel in lethal form of prostate cancer
An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted ...
Cancer
Nov 17, 2011 |
5 / 5 (1) |
1
|
New mouthwash may render cavities a thing of the past
(Medical Xpress) -- A new mouthwash developed by a microbiologist at the UCLA School of Dentistry is highly successful in targeting the harmful Streptococcus mutans bacteria that is the principal cause tooth decay and cavities.
Health
Nov 16, 2011 |
4.6 / 5 (13) |
33
|
Scientists design experimental treatment for iron-overload diseases
Iron overload is a common condition affecting millions of people worldwide. Excess iron in the body is toxic, and deposits can cause damage to the liver, heart and other organs. Current treatments, researchers ...
Medical research
Nov 01, 2011 |
not rated yet |
0
|
Lab-made skin cells will aid transplantation, cancer, drug discovery research
The pigmented cells called melanocytes aren't just for making freckles and tans. Melanocytes absorb ultraviolet light, protecting the skin from the harmful effects of the sun. They also are the cells that ...
Medical research
Oct 26, 2011 |
not rated yet |
0
|
Dirty packing plant blamed for killer cantaloupes
A dirty packing facility at a Colorado farm was the likely source of an outbreak of listeria in cantaloupes that killed 25 people in the US since August, health authorities said Wednesday.
Diseases, Conditions, Syndromes
Oct 19, 2011 |
5 / 5 (2) |
0
New Stanford regimen frees kidney-transplant patients from dependency on immunosuppresant drugs
Investigators at the Stanford University School of Medicine have developed a novel protocol that allows kidney-transplant recipients to jettison their indispensable immune-suppressing drugs. The protocol could also spell ...
Medications
Oct 05, 2011 |
4.7 / 5 (3) |
0
